Oct 7, 2026 08:00AM
Oct 5, 2026 08:00AM
Oct 1, 2026 08:00AM
Sep 2, 2025 07:32AM
Sep 2, 2025 07:30AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM PharmaTher Announces FDA Approval of Ketamine (KETARx™)
Jun 18, 2025 08:00AM
May 2, 2023 07:30AM
Apr 3, 2023 07:00AM
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™ (Ketamine) for the Treatment of Rett Syndrome
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM
Jan 11, 2023 08:15AM
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease
Sep 29, 2022 07:00AM
Sep 16, 2022 07:00AM
Sep 7, 2022 07:00AM
Jul 13, 2022 07:00AM
Jun 29, 2022 07:00AM
Jun 7, 2022 07:00AM
May 25, 2022 07:00AM PharmaTher To Develop and Commercialize Novel Wearable Ketamine Delivery Device in Collaboration with CCBIO
May 5, 2022 07:00AM
Apr 25, 2022 05:06PM
Apr 12, 2022 07:00AM
Mar 23, 2022 07:00AM
Mar 1, 2022 08:19AM
Feb 16, 2022 07:00AM
Feb 1, 2022 07:00AM PharmaTher Granted FDA Orphan Drug Designation for Ketamine to Treat Status Epilepticus
Jan 17, 2022 08:17AM
Jan 12, 2022 07:00AM
Jan 4, 2022 07:00AM
Dec 21, 2021 07:00AM
Dec 20, 2021 07:00AM
Dec 14, 2021 07:00AM
Nov 30, 2021 07:00AM PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio
Nov 24, 2021 07:30AM
Nov 11, 2021 07:59AM
Nov 3, 2021 07:30AM
Nov 3, 2021 07:00AM
Nov 1, 2021 09:30AM
Oct 27, 2021 05:34PM
Oct 27, 2021 08:49AM World Leading Drug Delivery Researcher Professor Ryan Donnelly Joins PharmaTher as Scientific and Technical Advisor
Oct 19, 2021 07:00AM

335,394 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All